D. Western Therapeutics Institute
4576
Migalo Holdings
5535
Bleach
9162
Next Generation Technology Group
319A
Suncall
5985
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 27.15%3.89B | 24.55%13.91B | 24.46%3.4B | 24.33%3.06B | 41.22%11.17B | 3.12B | 46.12%2.85B | 41.01%2.73B | 36.02%2.46B | 29.30%7.91B |
Cost of revenue | 30.76%1.09B | 27.27%3.77B | 23.89%878.77M | 27.11%829.9M | 32.87%2.96B | 802.42M | 38.94%794.13M | 21.33%709.29M | 31.55%652.91M | 25.97%2.23B |
Gross profit | 25.80%2.81B | 23.57%10.15B | 24.66%2.52B | 23.33%2.23B | 44.50%8.21B | 2.32B | 49.09%2.06B | 49.50%2.03B | 37.70%1.81B | 30.65%5.68B |
Operating expense | 40.17%1.69B | 24.58%5.61B | 28.75%1.39B | 14.85%1.2B | 49.07%4.5B | 1.18B | 38.68%1.2B | 45.90%1.08B | 66.54%1.05B | 34.62%3.02B |
Operating profit | 9.00%1.12B | 22.35%4.54B | 20.01%1.14B | 35.00%1.03B | 39.32%3.71B | 1.15B | 66.69%854.83M | 53.81%948.51M | 11.21%761.93M | 26.42%2.66B |
Net non-operating interest income (expenses) | 0 | 206.37%4.01M | 187.50%69K | 2.48%1.57M | -218.30%-3.77M | -6.89M | 0.00%1.57M | 9.09%24K | -2.42%1.53M | 123.32%3.19M |
Non-operating interest income | --0 | 25.41%4.01M | 187.50%69K | 0.00%1.57M | 0.35%3.2M | --32K | 0.00%1.57M | 9.09%24K | 0.00%1.57M | 0.31%3.19M |
Non-operating interest expense | ---- | --0 | --0 | --0 | --38K | --0 | --0 | --0 | --38K | ---- |
Total other finance cost | ---- | ---- | ---- | ---- | --6.93M | ---- | ---- | ---- | ---- | ---- |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -100M | 0 | ||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 99.76%-88K | 0 | 0 | -431.81%-36.56M | 107K | 0 | 0 | -9,398.19%-36.66M | 11.02M | |
Less:Restructuring and mergern&acquisition | ---- | --0 | --0 | --0 | --36.66M | --0 | --0 | --0 | --36.66M | ---- |
Less:Other special charges | ---- | 182.24%88K | ---- | ---- | 99.03%-107K | ---- | ---- | ---- | ---- | ---11.02M |
Other non-operating income (expenses) | -1,870.12%-2.9M | 87.40%-3.59M | 163.64%21K | 191.11%164K | -485.85%-28.46M | -28.28M | -98.41%30K | 99.65%-33K | -1,047.37%-180K | 476.13%7.38M |
Income before tax | 8.53%1.12B | 21.93%4.44B | 20.02%1.14B | 41.80%1.03B | 35.64%3.64B | 1.11B | 66.64%856.24M | 52.68%948.5M | 5.87%726.61M | 28.40%2.69B |
Income tax | 10.88%363.49M | 31.74%1.35B | 27.01%369.49M | 48.88%327.83M | 14.89%1.02B | 282.13M | 28.17%228.2M | 35.39%290.93M | -7.28%220.19M | 34.19%889.05M |
Net income | 7.44%754.73M | 18.10%3.1B | 16.93%768.91M | 38.72%702.49M | 45.90%2.62B | 828.75M | 87.03%628.04M | 61.82%657.57M | 12.83%506.42M | 25.71%1.8B |
Net income continuous operations | 7.44%754.73M | 18.10%3.1B | 16.93%768.91M | 38.72%702.49M | 45.90%2.62B | --828.75M | 87.03%628.04M | 61.82%657.58M | 12.83%506.42M | 25.71%1.8B |
Noncontrolling interests | -814K | 1.44M | 0 | |||||||
Net income attributable to the company | 7.55%755.55M | 18.05%3.09B | 16.93%768.91M | 38.72%702.49M | 45.90%2.62B | 828.75M | 87.03%628.04M | 61.82%657.57M | 12.83%506.42M | 25.71%1.8B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 7.55%755.55M | 18.05%3.09B | 16.93%768.91M | 38.72%702.49M | 45.90%2.62B | 828.75M | 87.03%628.04M | 61.82%657.57M | 12.83%506.42M | 25.71%1.8B |
Gross dividend payment | ||||||||||
Basic earnings per share | 7.03%17.81 | 14.62%73.16 | 12.76%18.2 | 32.17%16.64 | 42.70%63.83 | 19.94 | 81.34%15.16 | 59.66%16.14 | 12.40%12.59 | 25.26%44.73 |
Diluted earnings per share | 7.71%17.61 | 15.37%72.27 | 13.08%17.9 | 37.28%16.35 | 48.82%62.64 | 19.94 | 86.15%14.65 | 56.60%15.83 | 6.33%11.91 | 25.68%42.09 |
Dividend per share | 0 | 23.08%16 | 0 | 0 | 44.44%13 | 13 | 0 | 0 | 0 | 25.00%9 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |